Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:CEO |
gptkb:Arthur_Levinson
|
| gptkbp:collaboratesWith |
AbbVie
|
| gptkbp:focusesOn |
molecular biology
biochemistry biological research biomarkers chronic disease management clinical trials drug development gene therapy personalized medicine scientific research therapeutic interventions health technology clinical research genomics regenerative medicine therapeutics population health management aging process health informatics proteomics digital health solutions health economics patient-centered research stem cell research disease mechanisms artificial intelligence in medicine metabolomics preventive medicine health outcomes research translational medicine cell therapy health and longevity health policy research biomedical innovation cellular biology big data in health research data science in healthcare machine learning in healthcare healthcare_analytics healthcare_innovation |
| gptkbp:founded |
2013
|
| gptkbp:foundedBy |
gptkb:Google
|
| gptkbp:headquarters |
gptkb:South_San_Francisco,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Calico Life Sciences
|
| gptkbp:investmentFocus |
$1.5 billion
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:mission |
to understand the biology that controls lifespan.
|
| gptkbp:partnerships |
gptkb:Harvard_University
gptkb:Stanford_University gptkb:University_of_California,_San_Francisco gptkb:Scripps_Research_Institute Calico's_research_partners |
| gptkbp:partOf |
gptkb:Alphabet_Inc.
|
| gptkbp:researchAreas |
age-related diseases
genetics biomedical research drug_discovery |
| gptkbp:type |
private company
|
| gptkbp:website |
www.calicolabs.com
|